Rapid identification system of frontal dysfunction in subclinical hepatic encephalopathy
Journal Title: Annals of Hepatology - Year 2016, Vol 15, Issue 4
Abstract
Introduction and aim. Liver disease is associated with cognitive dysfunction also at early stages, and minimal hepatic encephalopathy, affecting 20-70% of patients, is frequently under-recognized. The main purpose of this work was to demonstrate that a substantial number of patients, enrolled due to an acute confusional state in absence of a diagnosis of liver disease, suffers of hepatic encephalopathy. Material and methods. Before a diagnosis of a well-compensated liver diseases was performed, 410 patients with an acute confusional state were enrolled in this study. Results. Even in the presence of minimal alterations of hepatic function, the psychometric tests applied demonstrated early signs of cerebral frontal alteration. The alteration was associated with the severity of liver disease, paralleling the progression of the patient to minimal hepatic failure or chronic liver disease. Conclusions. These psychometric tests are essential to detect early and subclinical frontal failure. Frontal dysfunction may be a useful tool in the follow-up of these patients.
Authors and Affiliations
Rita Moretti, Silvia Gazzin, Lory Crocè, Beatrice Baso, Flora Masutti, Giorgio Bedogni, Claudio Tiribelli
Keywords
Related Articles
- EP ID EP78601
- DOI 10.5604/16652681.1203153
- Views 100
- Downloads 0
Budd-Chiari syndrome after treatment with budesonide in a cirrhotic patient with autoimmune hepatitis
Trans-arterial 90yttrium radioembolization for patients with unresectable tumors originating from the biliary tree
Patients with malignant tumors originating from the biliary tree have a poor prognosis, since only a minority of tumors can be resected and most palliative regimens have shown only limited success. We present two patient...
Advanced hepatocellular carcinoma. Review of targeted molecular drugs
Hepatocellular carcinoma (HCC) is the sixth most common cancer in the world in terms of incidence, accounting for approximately 630 thousand new cases per year; in addition, HCC is the third most common cause of cancer d...
Association of plasma visfatin with hepatic and systemicinflammation in nonalcoholic fatty liver disease
Background. Visfatin is a proinflammatory and insulin-mimetic adipokine contributing to whole body glucose and lipid metabolism. Studies to date are conflicting regarding the relationship between visfatin and non-alcohol...
Citrus auraptene: A potential multifunctional therapeutic agent for nonalcoholic fatty liver disease